Prawira Oka

Dr. Prawira Oka

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 August 2023 in Vaccines
Verified
Journal Article
Open access
PDF file
STShyn Yi Tan
Shyn Yi Tan
POPrawira Oka
Prawira Oka
NTNgiap Chuan Tan
Ngiap Chuan Tan
Background: Multiple COVID-19 vaccines have been approved for use in adolescents; these vaccines play a critical role in limiting the transmission and impact of COVID-19. This systematic review aims to summarize the willingness of adolescents aged 10 to 19 years to receive the COVID-19 vaccination and the factors influencing their decision. Methods: A search of literature published between January 2018 and August 2022 was performed in Medline©, EMBASE©. and CINAHL© electronic databases. Studies published in English that assessed adolescents’ intentions to receive the COVID-19 vaccine were included. Qualitative studies and those unrelated to the COVID-19 vaccine were excluded. The study was conducted based on the PRISMA guidelines. Results: Of the 1074 articles retrieved, 13 were included in the final review. Most studies were conducted in the US (n = 3) and China (n = 3). The pooled prevalence of COVID-19 vaccine acceptance among adolescents was 63% (95% CI: 52–73%). Factors influencing intent to vaccinate were divided into five categories: “Socio-demographic determinants”; “Communication about COVID-19 pandemic and vaccination”; “COVID-19 vaccine and related issues”; “COVID-19 infection and related issues” and “Other determinants”. The enablers were sociodemographic factors including older age, higher education level, good health perception, and parental norms in terms of parental vaccination acceptance; perceived vaccine effectiveness and safety; a desire to protect themselves and others; recent vaccination; and anxiety. The barriers were concerns over vaccine effectiveness, safety, and long-term side effects; low perceived necessity and risk of infection; and needle phobia. Conclusions: This review highlighted that adolescents’ intent to vaccinate is driven by a desire to protect themselves and others. However, concerns over vaccine effectiveness, safety, and long-term side effects hinder COVID-19 vaccine uptake. To improve vaccination acceptance, policymakers should address adolescents’ concerns via more targeted public health messaging, while schools should leverage peer norms to positively influence vaccination intent.

28 June 2022 in Frontiers in Public Health
Verified
Journal Article
Open access
POPrawira Oka
Prawira Oka
BTBenecia Wan Qing Thia
Benecia Wan Qing Thia
SGShyna Zhuoying Gunalan
Shyna Zhuoying Gunalan
JKJanae Rae Yann Kwan
Janae Rae Yann Kwan
DNDing Xuan Ng
Ding Xuan Ng
NTNgiap Chuan Tan
Ngiap Chuan Tan
Background: COVID-19 vaccination is a key public health measure to mitigate the crippling effects of the pandemic. COVID-19 vaccination began in adults and targeted adolescents at a later stage. However, medical decision-making on its uptake among the latter was unknown, which could be affected by their literacy and concerns about the vaccine. The study aimed to elucidate the awareness, concerns and barriers of adolescents toward the COVID-19 vaccine.Methods: A cross-sectional online survey using a self-developed questionnaire was conducted between June to November 2021. The adolescent participants were students from institutes of post-secondary education who were recruited via convenience sampling. The data were collated from an officially approved electronic platform, audited and analyzed. Continuous and categorical variables were expressed as mean (standard deviation) and percentages, respectively.Results: A total of 460 adolescents participated in the study (mean age: 16.99 ± 0.99; 73% female). Most of them (91.5%) were aware of the COVID-19 vaccines. The main barriers to vaccination were uncertainty about long-term health risks (38.6%) and vaccine efficacy (37.3%). Regarding the potential vaccine side effects, they were concerned about: anaphylactic shock (73.2%), low blood pressure (58.3%) and fast heartbeat (58.0%). Only 58% expressed willingness for repeated COVID-19 vaccination.Conclusion: Despite high COVID-19 vaccine awareness, the adolescents were concerned about the potentially severe but rare side-effects. The study identified apprehension regarding vaccine efficacy and the potential long-term health impact as the main barriers to vaccination. Future studies should address these concerns to scale vaccination programs among adolescents.

1 July 2025 in Journal of Primary Care & Community Health
Verified
Journal Article
Open access
SSSwetha SKumar
Swetha SKumar
CNChirk Jenn Ng
Chirk Jenn Ng
POPrawira Oka
Prawira Oka
CLChui Yee Loke
Chui Yee Loke
SHStephanie Teo Swee Hong
Stephanie Teo Swee Hong
LNLok Pui Ng
Lok Pui Ng
Background: Continuity of care (CoC) has been proven to improve patient-doctor relationship and patient health outcomes. However, challenges in providing CoC by a team, instead of a single care provider, is seldom explored. This study aimed to identify the implementation challenges in delivering CoC through a newly implemented team-based care model. Methods: A qualitative study involving interviews of 39 healthcare providers and 7 patients was conducted across 2 polyclinics between January and April 2023. Two researchers conducted the interviews using semi-structured interview guides. The interviews were audio-recorded, transcribed verbatim, and analysed in NVivo using a thematic approach. Results: While patients and providers recognised the importance of CoC, incorporating the concept into the existing clinical care pathway was challenging. The key barriers that hindered establishing CoC were: lack of manpower and prioritisation of the team-based care model, uncertainty of ‘who’ is in the team, lack of access to relevant and timely information to address patients’ care needs, and patients’ difficulty in understanding the ‘1-patient, 1-team’ concept. Conclusion: While the team-based care model was well received, systemic barriers hindered its implementation. Addressing issues like IT system redesign and manpower allocation is essential for successfully embedding CoC within team-based care in Singapore’s primary care setting.

1 January 2024 in Journal of Primary Care & Community Health
Verified
Journal Article
Open access
POPrawira Oka
Prawira Oka
AMAminath Shiwaza Moosa
Aminath Shiwaza Moosa
CNChirk Jenn Ng
Chirk Jenn Ng
Background: Globally, most patients with hypertension have suboptimal blood pressure (BP) control. Multiple barriers prevent primary care physicians (PCPs) from effectively caring for these patients. This study aimed to explore the challenges faced by PCPs in providing optimal care for patients with hypertension, with a specific focus on identifying new barriers. Methods: This qualitative study involved 17 PCPs across 5 primary care clinics in Singapore. A trained researcher conducted individual in-depth interviews using a topic guide. Purposive sampling was employed to ensure adequate representation of seniority until data saturation was achieved. The audio-recorded interviews were transcribed verbatim and independently checked. The data were managed using NVivo and thematic analysis was conducted. Results: New barriers were divided into patient, physician, drug, and systemrelated factors. Patient factors included a preference for natural health remedies and the inconvenience of blood tests. Meanwhile, physicians faced challenges diagnosing and treating patients with various BP phenotypes and BP variability. The initiation of dual therapy was a drugrelated barrier. Finally, system factors included the suboptimal layout of the electronic medical records (EMR) that impeded effective hypertension management. Conclusion: A multi-pronged approach is required to address the significant barriers to providing optimal hypertension care. Patients should be empowered through education and minimizing the inconvenience of medication titrations. Additionally, physicians should be better equipped to diagnose and treat patients with more challenging BP phenotypes. Finally, improved access to combination pills and an optimized EMR would contribute to improved care for patients with hypertension.

1 February 2025 in Proceedings of Singapore Healthcare
Verified
Journal Article
Open access
JLJing Yi Lim
Jing Yi Lim
POPrawira Oka
Prawira Oka
LOLynette Ong
Lynette Ong
JPJannathnisha Binte Mohideen Pitchay
Jannathnisha Binte Mohideen Pitchay
WNWei Ling Ng
Wei Ling Ng
Background: White coat hypertension (WCH) is characterized by elevated clinic blood pressure (BP) measurements and normal out-of-clinic readings. Once considered benign, emerging evidence suggests WCH is associated with increased cardiovascular risk and mortality. Methods: This feasibility study was conducted at a primary care clinic in Singapore between November 2019 and October 2023. Individuals with elevated clinic BP were recruited through convenience sampling. Data was collected across two visits via an interviewer-administered questionnaire and a weeklong self-measured BP monitoring program. Home BP readings were interpreted utilizing three methods: (1) average of all readings, (2) 2018 ESH/ESC guidelines, and (3) clinician “eyeball method”. WCH was diagnosed in individuals with elevated clinic BP readings and normal home BP readings. Results: Sixty individuals were recruited, with a mean age of 61.8 ± 9.6 years, most were Chinese (90%) and married (63%). Nearly half the participants had hyperlipidemia with 56.7% overweight or obese. WCH was diagnosed in 23.3% of participants, while 35% were newly diagnosed with hypertension. None of the individuals with WCH reported significant anxiety as assessed using the GAD-7 scale. The clinician “eyeball method” resulted in five more individuals being diagnosed with hypertension compared to the 2018 ESH/ESC method. Conclusion: Over half of individuals with elevated clinic BP had WCH or undiagnosed hypertension. Primary care physicians should promote home BP self-monitoring and adopt standardized guideline-based methods for home BP interpretation. Future research should explore practical strategies to assimilate guidelines to real-world practice, improving diagnostic accuracy and treatment.

7 September 2023 in Frontiers in Medicine
Verified
Journal Article
Open access
POPrawira Oka
Prawira Oka
WCWei Ming Chong
Wei Ming Chong
DNDing Xuan Ng
Ding Xuan Ng
WAWai Keong Aau
Wai Keong Aau
NTNgiap Chuan Tan
Ngiap Chuan Tan
Background: Gout is associated with significant morbidity and mortality, yet suboptimal gout control remains a problem globally. Identifying the risk factors associated with poor gout control among patients in primary care allows targeted interventions to improve their clinical management. This study aimed to determine the prevalence of poor gout control and its associated demographic and clinical factors among urbanized community-dwelling Asian patients.Methods: This retrospective study was based on data extracted from the electronic medical records of 8 public primary care clinics in Singapore. Patients with a diagnostic code of gout who had 2 or more visits between 1st January 2018 and 31st December 2019 were included in the analysis. Data extracted included: demographics, anthropological measurements, comorbidities, serum uric acid levels and medication prescription. A patient is defined to have poor gout control if they suffer two or more acute gout attacks within a year. Chi-Squared test was used for categorical parameters. For continuous variables, univariate logistic regression analysis was first performed. Significant factors (p ≤ 0.1) were then included in the logistics regression model to account for confounders.Results: A total of 7,970 patients and 24,624 visits were included in the analysis. The prevalence of poorly controlled gout was 28.2% (n = 2,244/7,970); only 46.3% of them (n = 1,039/2,244) were prescribed allopurinol and 13.4% (n = 301/2,244) were taking doses ≥300 mg. Using logistic regression, factors associated with poor gout control were: male gender [adjusted OR (AOR) =1.66, p < 0.001], Malay ethnicity (AOR = 1.27, p = 0.007), congestive heart failure (AOR = 1.64, p = 0.037). Patients prescribed allopurinol (AOR = 1.52, p < 0.001), NSAIDs (AOR = 2.76, p < 0.001) and corticosteroids (AOR = 2.83, p < 0.001) were more likely to have poorly-controlled gout.Conclusion: Nearly 30% of patients had poor gout. Interventions should focus on male and Malay patients and those with congestive cardiac failure.